U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Norden Group LLC

Norden Group LLC reduced its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 12.7% during the 4th quarter, HoldingsChannel.com reports. The fund owned 3,293 shares of the company’s stock after selling 477 shares during the quarter. Norden Group LLC’s holdings in U.S. Physical Therapy were worth $307,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in USPH. True North Advisors LLC grew its stake in shares of U.S. Physical Therapy by 4.6% in the fourth quarter. True North Advisors LLC now owns 6,019 shares of the company’s stock valued at $561,000 after buying an additional 265 shares in the last quarter. Swiss National Bank grew its holdings in shares of U.S. Physical Therapy by 0.9% in the third quarter. Swiss National Bank now owns 32,400 shares of the company’s stock valued at $2,972,000 after purchasing an additional 300 shares in the last quarter. Oppenheimer Asset Management Inc. boosted its holdings in U.S. Physical Therapy by 1.7% in the third quarter. Oppenheimer Asset Management Inc. now owns 19,081 shares of the company’s stock valued at $1,750,000 after purchasing an additional 316 shares during the period. Bridge City Capital LLC grew its stake in U.S. Physical Therapy by 1.1% during the 3rd quarter. Bridge City Capital LLC now owns 31,372 shares of the company’s stock worth $2,878,000 after purchasing an additional 336 shares in the last quarter. Finally, Portside Wealth Group LLC raised its position in U.S. Physical Therapy by 10.8% in the 4th quarter. Portside Wealth Group LLC now owns 4,419 shares of the company’s stock valued at $412,000 after purchasing an additional 429 shares in the last quarter.

Analysts Set New Price Targets

A number of brokerages have recently commented on USPH. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Monday, March 18th. Barrington Research lifted their target price on U.S. Physical Therapy from $120.00 to $122.00 and gave the stock an “outperform” rating in a research report on Friday, March 1st. Finally, JPMorgan Chase & Co. upped their target price on U.S. Physical Therapy from $99.00 to $117.00 and gave the company an “overweight” rating in a research report on Wednesday, March 13th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and an average target price of $125.67.

U.S. Physical Therapy Stock Down 0.0 %

Shares of NYSE:USPH opened at $101.46 on Thursday. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.28 and a quick ratio of 2.28. The stock has a market cap of $1.53 billion, a P/E ratio of 75.16, a P/E/G ratio of 4.82 and a beta of 1.39. U.S. Physical Therapy, Inc. has a 1-year low of $78.08 and a 1-year high of $124.11. The firm has a fifty day moving average price of $105.01 and a 200 day moving average price of $95.74.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Wednesday, February 28th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.57 by $0.02. The business had revenue of $154.80 million during the quarter, compared to the consensus estimate of $150.24 million. U.S. Physical Therapy had a net margin of 4.67% and a return on equity of 8.52%. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.58 earnings per share. Sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.77 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, March 12th were paid a $0.44 dividend. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.43. This represents a $1.76 annualized dividend and a dividend yield of 1.73%. The ex-dividend date of this dividend was Monday, March 11th. U.S. Physical Therapy’s dividend payout ratio (DPR) is 130.37%.

Insider Activity

In related news, CFO Carey P. Hendrickson sold 1,800 shares of U.S. Physical Therapy stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the transaction, the chief financial officer now directly owns 21,186 shares in the company, valued at approximately $2,272,834.08. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other U.S. Physical Therapy news, EVP Richard Binstein sold 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $106.55, for a total value of $213,100.00. Following the sale, the executive vice president now owns 15,006 shares of the company’s stock, valued at approximately $1,598,889.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Carey P. Hendrickson sold 1,800 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $107.28, for a total value of $193,104.00. Following the completion of the sale, the chief financial officer now directly owns 21,186 shares of the company’s stock, valued at $2,272,834.08. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 10,829 shares of company stock valued at $1,141,535. Company insiders own 1.80% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.